تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
Linde plc's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $220.2B | |
|---|---|---|
| Revenue (ttm) | 35.4B | |
| Net income (ttm) | 7.2B | |
| EPS (ttm) | $15.5 | |
| Shares out | 461M | |
| P/E (trailing) | 32.8x | |
| P/E (forward) | 24.5x | |
| Dividend | $6.40 (1.26%) | |
| Volume | 1,632,304 | |
| Beta | 0.71 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $30.79B | $33.36B | $32.85B | $33.01B | $33.99B | +2.5% |
| Gross profit | $8.62B | $9.71B | $11.55B | $12.08B | $14.73B | +14.3% |
| Operating income | $4.98B | $5.37B | $8.02B | $8.64B | $8.92B | +15.7% |
| Net income | $3.83B | $4.15B | $6.20B | $6.57B | $6.90B | +15.9% |
| EPS (diluted) | $7.33 | $8.23 | $12.59 | $13.62 | $14.61 | +18.8% |
| EBITDA | $9.89B | $9.94B | $12.29B | $12.92B | $12.95B | +7.0% |
| R&D | $143.0M | $143.0M | $146.0M | $150.0M | $147.0M | +0.7% |
| SG&A | $3.19B | $3.11B | $3.30B | $3.34B | $3.43B | +1.9% |
Recent company headlines from major financial publishers.
The base path supports $266.68, but the shares remain rated Sell because the earnings path does not close the gap to $468.38 (as of 2026-09-08).
This case depends on the stated regional growth and cash-after-investment conditions. It is disconfirmed if recurring capex or valuation normalization overwhelms the earnings path.
| Ke ↓ / g → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.1% | $295 | $303 | $314 | $327 | $346 |
| 7.1% | $273 | $278 | $285 | $292 | $302 |
| 8.1% | $256 | $260 | $267 | $269 | $275 |
| 9.1% | $242 | $245 | $248 | $251 | $255 |
| 10.1% | $231 | $232 | $235 | $237 | $240 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
